Эффективность комбинации бисопролола с эутироксом и розувастатином в терапии фибрилляции предсердий на фоне гипотиреоза и дислипидемии

Fagim Kasymovich Rakhmatullov, Зиновьева Елена Григорьевна, Грачева Юлия Николаевна et al. · Известия высших учебных заведений. Поволжский регион. Медицинские науки · 2013

Background. The article aims at analyzing the efficacy of Bisoprolol-Euthyrox-Rosuvastatin combination in treating atrial fibrillation when exertional angina is combined with subclinical hypothyroidism and dyslipidemia. Materials and methods. The study involved the following methods: echocardiography, thyroid ultrasound, Holter monitoring, assessment of thyroid hormone level and blood lipid spectrum. Results. The authors analyzed the way Bisoprolol-Euthyrox-Rosuvastatin combination influences thyroid volume and function, cardiac hemodynamic/electrophysiological parameters, the number and duration of paroxysmal atrial fibrillation episodes when exertional angina is combined with subclinical hypothyroidism and dyslipidemia. Conclusions. The research findings suggest that Bisoprolol-Euthyrox-Rosuvastatin combination is a promising option to treat patients with paroxysmal AF when exertional angina is combined with subclinical hypothyroidism and dyslipidemia.

Cited by 0 works.

Authors